Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

morpholinoanthracycline MX2

Known as: 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin, MX-2, morpholinoanthracycline MX-2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The environmental impact of the Three Gorges Reservoir (TGR) in China has raised widespread concern especially in relation to… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
Is this relevant?
2004
2004
BACKGROUND/AIMS Mx proteins are supposed to be strictly regulated by viruses or interferon-alpha (IFN-alpha). We used a non-viral… Expand
Is this relevant?
1993
1993
We performed a preliminary phase II clinical trial of MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in… Expand
Is this relevant?
1989
1989
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and… Expand
  • table 1
  • figure 1
  • table 4
  • table 2
  • table 3
Is this relevant?
1988
1988
MX-2, a new morpholino anthracycline derivative, showed broad anti-neoplastic activity against experimental tumors. Molecular… Expand
Is this relevant?